arrow_back Back to App

Blood Clot Prevention and Treatment Act: Awareness, Diagnosis, and Surveillance

This Act aims to boost public awareness and improve the diagnosis of deep venous thrombosis (DVT) and pulmonary embolism (PE), conditions affecting hundreds of thousands of Americans annually. It mandates educational programs to help citizens recognize risk factors and symptoms, which is vital for early treatment and preventing fatalities. Furthermore, the Act establishes an advisory committee to develop care standards and recommendations for healthcare providers, directly leading to better health outcomes for individuals at risk of blood clots.
Key points
Increased Awareness and Education: The government will fund public information programs to teach citizens how to recognize blood clot symptoms and identify high-risk groups (e.g., pregnant women, seniors, hospitalized patients, Black Americans).
Improved Diagnosis and Care: An advisory committee, including experts and patients, will be established to develop best practices for healthcare providers regarding the detection, treatment, and prevention of blood clots.
Better Data Collection: Studies will be conducted to create model surveillance systems for tracking the prevalence and incidence of DVT/PE, allowing for more accurate problem assessment and effective health planning.
Funding: $20 million is authorized to be appropriated annually for fiscal years 2025 through 2029 to carry out these activities.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5699
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large]
Process start date: 2023-09-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Charles Rochester Blood Clot Prevention and Treatment Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_5699.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-26.

What are the main provisions?

Key points include:

  • Increased Awareness and Education: The government will fund public information programs to teach citizens how to recognize blood clot symptoms and identify high-risk groups (e.g., pregnant women, seniors, hospitalized patients, Black Americans).
  • Improved Diagnosis and Care: An advisory committee, including experts and patients, will be established to develop best practices for healthcare providers regarding the detection, treatment, and prevention of blood clots.
  • Better Data Collection: Studies will be conducted to create model surveillance systems for tracking the prevalence and incidence of DVT/PE, allowing for more accurate problem assessment and effective health planning.
  • Funding: $20 million is authorized to be appropriated annually for fiscal years 2025 through 2029 to carry out these activities.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Blunt Rochester, Lisa [D-DE-At Large].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health